https://pipelinereview.com/synthekine-presents-positive-initial-results-from-phase-1a-1b-clinical-trial-of-%ce%b1-%ce%b2-biased-il-2-stk-012-for-treatment-of-advanced-solid-tumors/
Synthekine Presents Positive Initial Results from Phase 1a/1b Clinical Trial of α/β Biased IL-2, STK-012, for Treatment of Advanced Solid Tumors